JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
NTLA Financials - Intellia Therapeutics Income & Cash Flow | Ledgeburg
NTLA - Intellia Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary NTLA Stock
Financials
Financials NTLA Stock
Loading...
Loading...
Income Statement
Income Statement NTLA Stock
Balance Sheet
Balance Sheet NTLA Stock
Cash Flow Statement
Cash Flow Statement NTLA Stock
Loading...
Loading...
Home
Stocks
Intellia Therapeutics, Inc. (NTLA)
Financials
Financials of NTLA
Loading...
Loading...
Loading...
Loading...
Revenue
$67.671M
Operating Income
$-440.99M
Net Income
$-412.694M
Share Count (Basic)
108.376M
Operating Cash Flow
$-394.736M
Free Cash Flow
$-395.865M
Cash And Short-Term Equivalents
$449.884M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
5M
10M
15M
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-500M
-450M
-400M
-350M
-300M
Annual
Quarterly
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-115M
-110M
-105M
-100M
-95M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-800%
-700%
-600%
-500%
-400%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26